Doctor profile · Federal record
Dr. VASEEM AKHTAR, M.D.
Specialist (CMS: MEDICAL ONCOLOGY) · Hematology (Internal Medicine) Physician · Medical Oncology Physician · OKEECHOBEE, FL
- NPI 1568660561
- Accepts Medicare
- MIPS 94.9 / 100 · 2023
- 44 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1713 HWY 441N, SUITE #J
OKEECHOBEE, FL 349721900
(863) 467-9000
fax (863) 467-9229 - Mailing address
-
1900 NEBRASKA AVE, SUITE #2
FT. PIERCE, FL 349504837
Credentials & registration
- NPI registered
- July 2007 — 19 yrs on file
- Profile last updated
- December 22, 2011
- Year of graduation
- 1982 — 44 yrs since
- Specialty taxonomy
- 174400000X — NUCC code
- State license (1)
- Florida #ME66653
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1568660561. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
35,723
Distinct HCPCS
10
Medicare allowed
$196,614
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J1756 |
Injection, iron sucrose, 1 mg | 33,141 | 44 | $0 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 544 | 69 | $94 | |
96365 |
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 445 | 45 | $66 | |
J7030 |
Infusion, normal saline solution , 1000 cc | 438 | 44 | $3 | |
96366 |
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 425 | 46 | $21 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 195 | 78 | $186 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 173 | 56 | $132 | |
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 101 | 57 | $120 | |
96372 |
Injection of drug or substance under skin or into muscle | 59 | 12 | $15 | |
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 50 | 34 | $80 |
In context: peer comparison
Among 1 peers in this city , average services per provider: 2,551. This provider delivers 14× the peer median.Open Payments
Industry payments received
All-time total
$443
Transactions
19
Manufacturers
8
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| PFIZER INC. | 5 | $117.74 | |
| Merck Sharp & Dohme LLC | 5 | $106.39 | |
| GENZYME CORPORATION | 4 | $96.19 | |
| Novartis Pharmaceuticals Corporation | 1 | $32.94 | |
| AstraZeneca Pharmaceuticals LP | 1 | $26.93 | |
| Fennec Pharmaceuticals, Inc. | 1 | $26.01 | |
| TAIHO ONCOLOGY, INC. | 1 | $20.35 | |
| Celgene Corporation | 1 | $16.34 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
380
Patients
11
Total drug cost
$1,149,953
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Hydroxyurea | Generic | 66 | 11 | $1,971 |
| Dexamethasone Sodium Phosphate | Generic | 35 | 0 | $117 |
| Xgeva (Denosumab) | Brand | 33 | 0 | $104,951 |
| Ondansetron Hcl (Ondansetron Hcl/Pf) | Brand | 31 | 0 | $69 |
| Xtandi (Enzalutamide) | Brand | 29 | 0 | $426,577 |
| Keytruda (Pembrolizumab) | Brand | 25 | 0 | $305,979 |
| Letrozole | Generic | 25 | 0 | $369 |
| Famotidine (Famotidine/Pf) | Brand | 23 | 0 | $40 |
| Acyclovir | Generic | 22 | 0 | $359 |
| Lenalidomide | Generic | 17 | 0 | $241,888 |